In a filing, Vertex Pharmaceuticals, Inc revealed its EVP, Chief Scientific Officer ALTSHULER DAVID unloaded Company’s shares for reported $7178.0 on Nov 15 ’24. In the deal valued at $478.56 per share,15 shares were sold. As a result of this transaction, ALTSHULER DAVID now holds 25,813 shares worth roughly $11.92 million.
Then, ALTSHULER DAVID bought 15 shares, generating $7,178 in total proceeds.
Before that, WAGNER CHARLES F JR sold 3,000 shares. Vertex Pharmaceuticals, Inc shares valued at $1,554,810 were divested by the EVP & Chief Financial Officer at a price of $518.27 per share. As a result of the transaction, WAGNER CHARLES F JR now holds 44,137 shares, worth roughly $20.38 million.
Wells Fargo downgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to an Equal weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in mid December has reiterated a ‘”a Buy”‘ rating for it. Oppenheimer also remained covering VRTX and has decreased its forecast on December 19, 2024 with a “Perform” recommendation from previously “an Outperform” rating. Jefferies revised its rating on December 09, 2024. It rated VRTX as “a Buy” which previously was an “a Hold”.
Price Performance Review of VRTX
On Friday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock jump 5.31% to $461.68. Over the last five days, the stock has gained 5.02%. Vertex Pharmaceuticals, Inc shares have risen nearly 14.65% since the year began. Nevertheless, the stocks have risen 3.50% over the past one year. While a 52-week high of $519.88 was reached on 01/31/25, a 52-week low of $377.85 was recorded on 01/13/25. SMA at 50 days reached $437.71, while 200 days put it at $459.00.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 448.57, which if violated will result in even more drops to 435.47. On the upside, there is a resistance level at 473.41. A further resistance level may holdings at 485.15. The Relative Strength Index (RSI) on the 14-day chart is 67.81, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 15.08, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 13.85%. Stochastics %K at 85.13% indicates the stock is a selling.
How much short interest is there in Vertex Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc stocks on 2025-01-15, growing by 0.88 million shares to a total of 4.39 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 3.51 million shares. There was a rise of 20.07%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 14, 2024 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $575 price target.
